Project description
Enhancing prediction of severe adverse effects early in the drug development pipeline
Fields of science
Programme(s)
Coordinator
2000 Antwerpen
Belgium
See on map
Participants (10)
6200 MD Maastricht
See on map
NG7 2RD Nottingham
See on map
78153 Le Chesnay Cedex
See on map
Participation ended
2333 BD Leiden
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1070 Bruxelles
See on map
78230 LE P Le Pecq
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
12489 Berlin
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
55218 Ingelheim
See on map
7610001 Rehovot
See on map
2333 BD Leiden
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.